Skip to content
CancerIndex

Publication

[64Cu]CuCl2 as a Novel Metabolic Marker of Progression and Survival in Muscle-Invasive Bladder Cancer.

Francesco Fiz, Gianluca Bottoni, Monica Boitano, Martina Ugolini, Giulia Rosari, Giulia Magistrali, Michela Massollo, Massimiliano Iacozzi, Laura Tomasello, Fabio Campodonico, Diego Cecchin, Carlo Luigi Augusto Negro, Stefano Panareo, Luca Timossi, Giacomo Vallome, Giorgio Treglia, Carlo Introini, Arnoldo Piccardo

Molecular imaging and biologySep 2, 2026PMID 42686932doi:10.1007/s11307-026-02135-3 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 13, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260913-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

PURPOSE: Muscle-invasive bladder cancer (miBC) is an aggressive malignancy that can be visualised with [64Cu]Copper-dichloride ([64Cu]CuCl2) PET/CT, due to the increased copper avidity of this cancer. Moreover, [64Cu]CuCl2 could also show a predictive role in patients undergoing platinum-based…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.